AbbVie Inc. (LON:0QCV)
London flag London · Delayed Price · Currency is GBP · Price in USD
185.44
-1.22 (-0.65%)
At close: Jun 27, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
Immunology
26.68B
Log In
Log In
Log In
Log In
Upgrade
Immunology Growth
6.39%
Log In
Log In
Log In
Log In
Upgrade
Oncology
6.56B
Log In
Log In
Log In
Log In
Upgrade
Oncology Growth
9.98%
Log In
Log In
Log In
Log In
Upgrade
Other Key Products
3.65B
Log In
Log In
Log In
Log In
Upgrade
Other Key Products Growth
-5.85%
Log In
Log In
Log In
Log In
Upgrade
All Other
3.03B
Log In
Log In
Log In
Log In
Upgrade
All Other Growth
-1.72%
Log In
Log In
Log In
Log In
Upgrade
Neuroscience
9.00B
Log In
Log In
Log In
Log In
Upgrade
Neuroscience Growth
16.64%
Log In
Log In
Log In
Log In
Upgrade
Women's Health
-
Log In
Log In
Log In
Log In
Upgrade
Women's Health Growth
-
Log In
Log In
Log In
Log In
Upgrade
Aesthetics
5.18B
Log In
Log In
Log In
Log In
Upgrade
Aesthetics Growth
-4.08%
Log In
Log In
Log In
Log In
Upgrade
Eye Care
2.24B
Log In
Log In
Log In
Log In
Upgrade
Eye Care Growth
-5.76%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2012 - 2019
United States
43.03B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
5.38%
Log In
Log In
Log In
Log In
Upgrade
International
13.31B
Log In
Log In
Log In
Log In
Upgrade
International Growth
5.68%
Log In
Log In
Log In
Log In
Upgrade